BSE filing, BSE: 544694. Summary written from the filing by ALFA Finder's alert engine.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹311.00
- Market cap
- ₹225.2 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 44.4×Sector 37.9×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Investor Presentation: Key Takeaways
H1 FY27 (Apr–Sep 2026): revenue ₹29.44 Cr (+109.35% YoY), EBITDA ₹6.26 Cr (21.27% margin), PAT ₹4.73 Cr (16.06% margin). Focus on capacity expansion and product diversification.
Accretion Nutraveda Results Update
Accretion Nutraveda released a half-year media release showing revenue up 109.35% to Rs 29.44 crore. EBITDA rose 88.03% and PAT rose 98.66%.
Accretion Nutraveda H1 FY27 Results: Net Profit ₹4.7 Cr, Up 95.8% YoY
Accretion Nutraveda Ltd reported revenue from operations of ₹29.4 Cr (+108.5% YoY) and net profit of ₹4.7 Cr (+95.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.7 Cr · +95.8% YoY
Accretion Nutraveda Other Announcement
Accretion Nutraveda's quarterly shareholding pattern shows promoters holding 73.48%. The routine filing reports no corporate action or event value.
Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.
Other price movement clarification announcements
All →Abram Food Price Movement Clarification
Abram Food Limited clarified that recent equity share price movements are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or pending announcements.
Dhillon Freight Carrier Price Movement Clarification
Dhillon Freight Carrier Ltd clarified that recent share price movements are market-driven. The company confirmed no undisclosed material events or information exist that could affect its scrip behavior.
Innovision Price Movement Clarification
Innovision Ltd clarified that recent equity share price movements are market-driven with no undisclosed material information. The company confirmed full compliance with SEBI disclosure regulations.
Aegis Logistics Price Movement Clarification
Aegis Logistics clarified to BSE that the unusual volume surge is purely market-driven with no undisclosed information. The company confirmed compliance with Reg 30 LODR.
Marsons Price Movement Clarification
Marsons Ltd. replied to an exchange price-movement query stating no undisclosed information exists. The company affirmed compliance with LODR and no future disclosure is pending.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.